| A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease (NCT02836574) | Prokidney | 2016-09-01 |
| A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus (NCT02851849) | Ligand Pharmaceuticals | 2016-09-01 |
| Effect of Administration of Resveratrol on Glycemic Variability in Individuals With Type 2 Diabetes Mellitus (NCT02549924) | University of Guadalajara | 2016-09-01 |
| Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes Mellitus (NCT02924064) | Tanabe Pharma Corporation | 2016-09-01 |
| A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients (NCT02616666) | University of Liverpool | 2016-08-25 |
| Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic Therapy (NCT02855684) | Sanofi | 2016-08-24 |
| Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension (NCT02842359) | Sanofi | 2016-08-23 |
| Impact of Dapagliflozin on DIAstolic Dysfunction in Type 2 Diabetic Patients (NCT02751398) | Yonsei University | 2016-08-18 |
| Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects (NCT02769481) | Theracos | 2016-08-15 |
| A Peer Support Program to Enhance Treatment Adherence in Patients With Type 2 DM (NCT03294265) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2016-08-01 |
| Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy? (NCT02846233) | University of California, San Francisco | 2016-08-01 |
| Impact of Overfeeding and Following Exercise Training in Individuals With and Without Increased Risk of Type 2 Diabetes (NCT02982408) | Rigshospitalet, Denmark | 2016-08-01 |
| The Long-term Effect of Tianqi Capsule Interventions to Prevent Diabetes in the REDUCES Study: a 8-year Follow-up Study (NCT02848053) | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 2016-08-01 |
| GLP-1/Basal Insulin Combination Therapy (NCT02895672) | Albany College of Pharmacy and Health Sciences | 2016-08-01 |
| Mi Puente: My Bridge to Better Cardiometabolic Health and Well-Being (NCT02723019) | Scripps Whittier Diabetes Institute | 2016-07-14 |
| Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita) (NCT02623998) | Population Health Research Institute | 2016-07-09 |
| Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period (NCT02787551) | Sanofi | 2016-07-06 |
| Effect of Fasting Therapy on Blood Glucose Control and Islet Function in Newly Diagnosed Type 2 Diabetic Patients (NCT02956655) | First Affiliated Hospital, Sun Yat-Sen University | 2016-07-01 |
| Vortioxetine vs Sertraline in Mexicans (NCT03978286) | Universidad Juárez Autónoma de Tabasco | 2016-06-30 |
| Study to Evaluate the Effects of a High-Fat Meal on Bexagliflozin in Healthy Subjects (NCT02820298) | Theracos | 2016-06-20 |
| A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848) (NCT02791490) | Merck Sharp & Dohme LLC | 2016-06-16 |
| Chronic Periodontitis Microbiota in Type 2 Diabetes Mellitus Patients (NCT03786133) | University of Bologna | 2016-06-10 |
| Microarchitecture, Bone Strength and Fracture Risk in Type 2 Diabetes (NCT02551315) | University Hospital, Basel, Switzerland | 2016-06-01 |
| Influence of Liraglutide, a GLP-1 Receptor Agonist, on Brown Adipose Tissue (BAT) Activity in Humans (NCT02718950) | University of Campinas, Brazil | 2016-06-01 |
| Correlation Between Change of HbA1c, Urinary Glucose Excretion and Other Factors in Patients Treated With Ipragliflozin (NCT02791035) | Asan Medical Center | 2016-06-01 |
| One Drop Experts Program for Type 2 Diabetes Self-Management: Impact on A1c (NCT02827669) | Evidation Health | 2016-06-01 |
| Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan (NCT02752828) | Sanofi | 2016-05-23 |
| Efficacy and Safety of LixiLan Versus Insulin Glargine Alone Both With Metformin in Japanese With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Drugs (NCT02752412) | Sanofi | 2016-05-17 |
| A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin (NCT02794792) | Astellas Pharma Europe B.V. | 2016-05-11 |
| The Effect of Exercise on Gut Microbiota in Type 2 Diabetic Patients (NCT03380338) | Amsterdam UMC, location VUmc | 2016-05-11 |
| Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan (NCT02749890) | Sanofi | 2016-05-09 |
| Randomized Sitagliptin Withdrawal Study (MK-0431-845) (NCT02738879) | Merck Sharp & Dohme LLC | 2016-05-09 |
| Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus" (NCT03555591) | Takeda | 2016-05-01 |
| Value-based Emotion-focused Educational Programme to Reduce Diabetes-related Distress (NCT02730078) | Universiti Putra Malaysia | 2016-04-01 |
| Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes (NCT02762370) | Pacira Pharmaceuticals, Inc | 2016-04-01 |
| Cut Down on Carbohydrate Usage in the Diet of Type 2 Diabetes (NCT02764021) | Bispebjerg Hospital | 2016-04-01 |
| Multiple Ascending Dose Study of GMC-252-L-Lys Salt in Healthy Subjects and Type 2 Diabetics (NCT02744820) | Genmedica Therapeutics S.L. | 2016-04-01 |
| Emotional Disorders and Outcomes in Adults With Type 2 Diabetes Mellitus at Primary Care (NCT02730754) | Universiti Putra Malaysia | 2016-04-01 |
| Postprandial Glucodynamic Response to Insulin Glargine/Lixisenatide Fixed Ratio Combination in Japanese Patients With Type 2 Diabetes Mellitus (NCT02713477) | Sanofi | 2016-04-01 |
| Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes Mellitus (NCT02737891) | Saniona | 2016-04-01 |
| The Application of the E-health Education on Shared Care Program for Patients With Type 2 Diabetes (NCT03061266) | Li-Li Chen | 2016-03-09 |
| Use of Canagliflozin in Conjunction With Insulin in a Real-world Setting (NCT02681497) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2016-03-01 |
| The Relationship Between Advanced Glycation Endproducts and Diabetes (NCT02662010) | University of Colorado, Denver | 2016-03-01 |
| Financial Incentives Telephone Education and Skills Trial in African Americans With Diabetes (FITEST) (NCT02722499) | State University of New York at Buffalo | 2016-03-01 |
| Effect of Moringa Oleifera on Metformin Plasma Level in Type 2 Diabetes Mellitus Patients (NCT03189407) | Titilayo O Fakeye | 2016-03-01 |
| Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas (NCT03983551) | Changhua Christian Hospital | 2016-03-01 |
| Technology-augmented Self-monitoring Model Among Patients With Type 2 Diabetes and Hypertension (NCT02799953) | The University of Hong Kong | 2016-03-01 |
| The Effect of Bariatric Surgery on Metabolism, the Metabolome and Microbiome in Patients With Type 2 Diabetes (NCT02762708) | Mayo Clinic | 2016-03-01 |
| Clinical Profile and Laboratory Finding of DFU From Tertiary Hospitals in Bali (NCT03939000) | Udayana University | 2016-03-01 |
| Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes (NCT02715258) | Theracos | 2016-03-01 |
| A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 Diabetes (NCT02681094) | AstraZeneca | 2016-02-26 |
| Effect of Aged Garlic Extract (AGE) on Improving Coronary Atherosclerosis in People With Type 2 Diabetes Mellitus (NCT03931434) | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 2016-02-23 |
| The Effectiveness of Low Carbohydrate Diet in Reducing Polypharmacy for Patients With Type 2 Diabetes Mellitus (NCT03176056) | National Taiwan University Hospital | 2016-02-02 |
| Heat Shock Response is Blunted in Elderly Diabetic People But Recovered by Strength Training (NCT03489083) | Federal University of Rio Grande do Sul | 2016-02-01 |
| TAPESTRY With Health Connnectors for Diabetes Management (NCT02715791) | McMaster University | 2016-02-01 |
| A 12/24-weeks, Open, Multi-centre, Phase IV Study on Safety and Efficacy of 2mg Exenatide Once Weekly (Bydureon) in T2DM Patients. (NCT02533453) | AstraZeneca | 2016-01-28 |
| Clinical Evaluation of Fenugreek Seed Extract, a Nutraceutical in Patients With Type- 2 Diabetes (NCT02693392) | All India Institute of Medical Sciences, Bhubaneswar | 2016-01-17 |
| Randomized Trial Comparing Colesevelam vs. Ezetimibe (NCT02682680) | LMC Diabetes & Endocrinology Ltd. | 2016-01-11 |
| Observational Study to Evaluate the Efficacy and Safety of Teneligliptin (NCT03793023) | Handok Inc. | 2016-01-05 |
| 12-Week Study of DS-8500a in Subjects With Type 2 Diabetes Mellitus on Metformin (NCT02647320) | Daiichi Sankyo | 2016-01-01 |
| Loop Duodenal Switch Surgery in Morbidly Obese Patients (NCT02671331) | Medical College of Wisconsin | 2016-01-01 |
| An Exploratory Study of DS-8500a on Beta Cell Function Using Hyperglycemic Clamp (NCT02669732) | Daiichi Sankyo Co., Ltd. | 2016-01-01 |
| Effects of Tianqi Capsule on Glucose Variability in Patients With Type 2 Diabetes. (NCT02617732) | Peking Union Medical College Hospital | 2016-01-01 |
| Glycemic Control and Endothelial Function in Patients With Type 2 Diabetes (NCT03480945) | Karolinska Institutet | 2016-01-01 |
| Effect of Gastric Bypass Surgery on Diabetes Status and Microvascular Complications in Obese Type 2 Diabetic Patients (NCT02625649) | University of Aarhus | 2016-01-01 |
| A Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus Receiving Sitagliptin (NCT02685345) | Daiichi Sankyo Co., Ltd. | 2016-01-01 |
| Effect of Green Tea Extract on Arterial Stiffness in Type 2 Diabetes Mellitus (NCT02627898) | Centro Universitario de Ciencias de la Salud, Mexico | 2016-01-01 |
| Improving Glycaemic Control in Malaysian Patients With Type 2 Diabetes Mellitus With Insulin Pump Therapy (NCT03112538) | Clinical Research Centre, Malaysia | 2016-01-01 |
| Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in Type 2 Diabetes (NCT02832999) | Yaounde Central Hospital | 2016-01-01 |
| Glimepiride, Alogliptin and Alogliptin+Pioglitazone Combination (NCT04470310) | Seoul National University Hospital | 2015-12-31 |
| A Study to Evaluate the Efficacy and Safety of Ertugliflozin in Asian Participants With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Monotherapy (MK-8835-012) (NCT02630706) | Merck Sharp & Dohme LLC | 2015-12-16 |
| Clinical Evaluation of Fenfuro (Fenugreek Seed Extract) in Type-2 Diabetic Subjects: an add-on Study (NCT03066089) | Chemical Resources | 2015-12-14 |
| A Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes Mellitus (NCT02548585) | MedImmune LLC | 2015-12-09 |
| Early Sleeve Gastrectomy In New Onset Diabetic Obese Patients (NCT02488733) | Azienda Ospedaliera Santa Maria, Terni, Italy | 2015-12-01 |
| Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Forxiga (NCT02561130) | Population Health Research Institute | 2015-12-01 |
| Comparison of MyStar DoseCoach to Routine Titration in Adult Patients With Type 2 Diabetes Mellitus Using Toujeo (NCT02585674) | Sanofi | 2015-12-01 |
| A Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 Diabetes (NCT02653599) | vTv Therapeutics | 2015-12-01 |
| Effect of DPP4 Inhibition on Vasoconstriction (NCT02639637) | Vanderbilt University | 2015-12-01 |
| Safety and Efficacy of Acarbose+Saxagliptin Compared With Metformin+Saxagliptin in Patients With Type 2 Diabetes (NCT02605772) | Fifth Affiliated Hospital, Sun Yat-Sen University | 2015-12-01 |
| Effect of Sitagliptin on Progression of Coronary Intermediate Lesion (NCT02655757) | Li Bo | 2015-12-01 |
| INTEGRA Study: Primary Care Intervention in Type 2 Diabetes Patients With Poor Glycaemic Control (NCT02663245) | Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | 2015-12-01 |
| Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843) (NCT02577003) | Merck Sharp & Dohme LLC | 2015-11-09 |
| Double-blind Sitagliptin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin (MK-0431J-842) (NCT02577016) | Merck Sharp & Dohme LLC | 2015-11-05 |
| FM-SRP and Tooth Extraction Improve Type 2 Diabetes Mellitus in Periodontitis (NCT02874963) | University Clinical Centre of Kosova | 2015-11-01 |
| Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes (NCT02449603) | Xijing Hospital | 2015-11-01 |
| A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus (NCT02597049) | Eli Lilly and Company | 2015-11-01 |
| Effects of Berberine Hydrochloride and Bifidobacterium in Diabetes Mellitus Prevention and Treatment (NCT02084004) | Xijing Hospital | 2015-11-01 |
| Transporters for Organic Cations and Glycemic Control in Patients With Neuropathic Pain. (NCT03047278) | Natalia Valadares de Moraes | 2015-11-01 |
| Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome (NCT02251431) | Baylor Research Institute | 2015-11-01 |
| Effect of Dapagliflozin on Inflammation and Endothelial Function (NCT02608905) | Baylor College of Medicine | 2015-11-01 |
| Fiber-enriched Buckwheat Pasta and Glucose Variability in Patients With Type 1 Diabetes and Celiac Disease (NCT03380988) | Federico II University | 2015-11-01 |
| Role of 12-lipoxygenase in Platelet Reactivity and Type 2 Diabetes Mellitus (NCT02629497) | University of Michigan | 2015-11-01 |
| Anti-Inflammatory Small Drug Adjunctive Therapy for Type 2 Diabetes (NCT02597101) | Nick Giannoukakis, PhD | 2015-11-01 |
| Dose-finding Study of LIK066 Compared With Placebo or Sitagliptin to Evaluate Change in HbA1c in Patients With Diabetes (NCT01824264) | Novartis Pharmaceuticals | 2015-11-01 |
| Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus (NCT03010683) | University of Athens | 2015-11-01 |
| Effects of Dietary Supplement Tauroursodeoxycholic Acid on Vascular Function (NCT03331432) | University of Missouri-Columbia | 2015-10-28 |
| Ipragliflozin Add-on Long-term Study in Japanese Participants With Type 2 Diabetes Mellitus on Sitagliptin (MK-0431J-849) (NCT02564211) | Merck Sharp & Dohme LLC | 2015-10-26 |
| The Effect of The Walking Exercise Training Given According to Transtheoretical Model, and Follow-Up on Improving Exercise Behavior and Metabolic Control in Type 2 Diabetic Patients (NCT03517527) | Emine KAPLAN SERIN | 2015-10-25 |
| A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin (NCT02551874) | AstraZeneca | 2015-10-20 |
| An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus (NCT02561078) | Eli Lilly and Company | 2015-10-20 |